NPNT
Nephronectin
Also known as: EGFL6L, NPNT_HUMAN, POEM
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6UXI9
- Gene
- NPNT
- Ensembl
- ENSG00000168743
- Chromosome
- 4
- Canonical length
- 565 aa
- Protein class
- Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Cell Junctions,Cytosol
- Secretome location
- Secreted to extracellular matrix
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
Predicted to enable integrin binding activity. Predicted to be involved in several processes, including cell-cell adhesion mediated by integrin; positive regulation of ERK1 and ERK2 cascade; and positive regulation of alkaline phosphatase activity. Predicted to act upstream of or within positive regulation of transforming growth factor beta receptor signaling pathway. Located in collagen-containing extracellular matrix and extracellular exosome. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
565 residues, UniProt reviewed canonical sequence.
>Q6UXI9|NPNT
1 MDFLLALVLV SSLYLQAAAE FDGRWPRQIV SSIGLCRYGG RIDCCWGWAR QSWGQCQPVC
61 QPRCKHGECI GPNKCKCHPG YAGKTCNQDL NECGLKPRPC KHRCMNTYGS YKCYCLNGYM
121 LMPDGSCSSA LTCSMANCQY GCDVVKGQIR CQCPSPGLQL APDGRTCVDV DECATGRASC
181 PRFRQCVNTF GSYICKCHKG FDLMYIGGKY QCHDIDECSL GQYQCSSFAR CYNIRGSYKC
241 KCKEGYQGDG LTCVYIPKVM IEPSGPIHVP KGNGTILKGD TGNNNWIPDV GSTWWPPKTP
301 YIPPIITNRP TSKPTTRPTP KPTPIPTPPP PPPLPTELRT PLPPTTPERP TTGLTTIAPA
361 ASTPPGGITV DNRVQTDPQK PRGDVFIPRQ PSNDLFEIFE IERGVSADDE AKDDPGVLVH
421 SCNFDHGLCG WIREKDNDLH WEPIRDPAGG QYLTVSAAKA PGGKAARLVL PLGRLMHSGD
481 LCLSFRHKVT GLHSGTLQVF VRKHGAHGAA LWGRNGGHGW RQTQITLRGA DIKSVVFKGE
541 KRRGHTGEIG LDDVSLKKGH CSEERLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NPNT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 225 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 225 nTPM
- blood vessel: 185 nTPM
- lung: 132 nTPM
- kidney: 100 nTPM
- prostate: 78 nTPM
- small intestine: 70 nTPM
Single-cell type
- podocytes: 1,852 nCPM
- alveolar cells type 1: 493 nCPM
- pituicytes/fscs: 452 nCPM
- transitional alveolar cells: 388 nCPM
- alveolar cells type 2: 323 nCPM
- renal collecting duct intercalated cells: 200 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 64 nTPM
- hypothalamus: 24 nTPM
- thalamus: 15 nTPM
- amygdala: 13 nTPM
- pons: 12 nTPM
- basal ganglia: 9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NPNT.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 129 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.09
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- branching involved in ureteric bud morphogenesis
- cell-cell adhesion mediated by integrin
- cell-matrix adhesion
- cellular response to tumor necrosis factor
- establishment of protein localization
- extracellular matrix organization
- pilomotor reflex
- positive regulation of cell-substrate adhesion
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of osteoblast differentiation
- positive regulation of smooth muscle contraction
- positive regulation of transcription by RNA polymerase II
- positive regulation of transforming growth factor beta receptor signaling pathway
- smooth muscle cell differentiation
- transforming growth factor beta receptor signaling pathway
- ureteric bud development
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- EGF-type aspartate/asparagine hydroxylation site
- EGF-like domain
- MAM domain
- EGF-like calcium-binding domain
- Growth factor receptor cysteine-rich domain superfamily
- Concanavalin A-like lectin/glucanase domain superfamily
- EGF-like calcium-binding, conserved site
- NELL2-like, EGF domain
- NOTCH1, EGF-like calcium-binding domain
- Nephronectin domain-containing protein
- MAM domain, meprin/A5/mu
- Calcium-binding EGF domain
- EGF domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NPNT as an antibody target. Whether an autoantibody or antibody against NPNT could matter depends on whether native NPNT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NPNT is annotated as secreted, so native NPNT circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label NPNT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...